AAAAAA

   
Results: 1-23 |
Results: 23
SMALL-CELL LUNG-CANCER - TREATMENT PROGRESS AND PROSPECTS
Authors: CLARK R IHDE DC
Citation: R. Clark et Dc. Ihde, SMALL-CELL LUNG-CANCER - TREATMENT PROGRESS AND PROSPECTS, Oncology, 12(5), 1998, pp. 647-658
SURVIVAL OF PATIENTS WITH LIMITED-STAGE SMALL-CELL LUNG-CANCER TREATED WITH INDIVIDUALIZED CHEMOTHERAPY SELECTED BY IN-VITRO DRUG-SENSITIVITY TESTING
Authors: CORTAZAR P GAZDAR AF WOODS E RUSSELL E STEINBERG SM WILLIAMS J IHDE DC JOHNSON BE
Citation: P. Cortazar et al., SURVIVAL OF PATIENTS WITH LIMITED-STAGE SMALL-CELL LUNG-CANCER TREATED WITH INDIVIDUALIZED CHEMOTHERAPY SELECTED BY IN-VITRO DRUG-SENSITIVITY TESTING, Clinical cancer research, 3(5), 1997, pp. 741-747
CLINICAL-PRACTICE GUIDELINES FOR THE TREATMENT OF UNRESECTABLE NON-SMALL-CELL LUNG-CANCER
Authors: SOMERFIELD MR IHDE DC PFISTER DG BAKER S BERNATH A BRESCIA FJ FONTENOT E GREEN MR JOHNSON DH OLAK J SAUSE W SMITH TJ STOVER D TURRISI AT WATERS P WINN RJ
Citation: Mr. Somerfield et al., CLINICAL-PRACTICE GUIDELINES FOR THE TREATMENT OF UNRESECTABLE NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 15(8), 1997, pp. 2996-3018
ALTERNATING MOPP AND ABVD CHEMOTHERAPY PLUS MANTLE-FIELD RADIATION-THERAPY IN PATIENTS WITH MASSIVE MEDIASTINAL HODGKINS-DISEASE
Authors: LONGO DL GLATSTEIN E DUFFEY PL YOUNG RC IHDE DC BASTIAN AW WILSON WH WITTES RE JAFFE ES HUBBARD SM DEVITA VT
Citation: Dl. Longo et al., ALTERNATING MOPP AND ABVD CHEMOTHERAPY PLUS MANTLE-FIELD RADIATION-THERAPY IN PATIENTS WITH MASSIVE MEDIASTINAL HODGKINS-DISEASE, Journal of clinical oncology, 15(11), 1997, pp. 3338-3346
OUTCOME OF PATIENTS WITH SMALL-CELL LUNG-CANCER DURING 20 YEARS OF CLINICAL RESEARCH AT THE US NATIONAL-CANCER-INSTITUTE
Authors: CHUTE JP VENZON DJ HANKINS L OKUNIEFF P FRAME JN IHDE DC JOHNSON BE
Citation: Jp. Chute et al., OUTCOME OF PATIENTS WITH SMALL-CELL LUNG-CANCER DURING 20 YEARS OF CLINICAL RESEARCH AT THE US NATIONAL-CANCER-INSTITUTE, Mayo Clinic proceedings, 72(10), 1997, pp. 901-912
PATIENTS WITH LIMITED-STAGE SMALL-CELL LUNG-CANCER TREATED WITH CONCURRENT TWICE-DAILY CHEST RADIOTHERAPY AND ETOPOSIDE CISPLATIN FOLLOWED BY CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE
Authors: JOHNSON BE BRIDGES JD SOBCZECK M GRAY J LINNOILA RI GAZDAR AF HANKINS L STEINBERG SM EDISON M FRAME JN PASS H NESBITT J HOLDEN D MULSHINE JL GLATSTEIN E IHDE DC
Citation: Be. Johnson et al., PATIENTS WITH LIMITED-STAGE SMALL-CELL LUNG-CANCER TREATED WITH CONCURRENT TWICE-DAILY CHEST RADIOTHERAPY AND ETOPOSIDE CISPLATIN FOLLOWED BY CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE, Journal of clinical oncology, 14(3), 1996, pp. 806-813
NCI-NAVY MEDICAL ONCOLOGY BRANCH CELL-LINE DATA-BASE
Authors: PHELPS RM JOHNSON BE IHDE DC GAZDAR AF CARBONE DP LINNOILA PRMRI MATTHEWS MJ BUNN PA CARNEY D MINNA JD MULSHINE JL
Citation: Rm. Phelps et al., NCI-NAVY MEDICAL ONCOLOGY BRANCH CELL-LINE DATA-BASE, Journal of cellular biochemistry, 1996, pp. 32-91
CORRELATION OF IN-VITRO DRUG-SENSITIVITY TESTING RESULTS WITH RESPONSE TO CHEMOTHERAPY AND SURVIVAL - COMPARISON OF NONSMALL CELL LUNG-CANCER AND SMALL-CELL LUNG-CANCER
Authors: SHAW GL GAZDAR AF PHELPS R STEINBERG SM LINNOILA RI JOHNSON BE OIE HK RUSSELL EK GHOSH BC PASS HI MINNA JD MULSHINE JL IHDE DC
Citation: Gl. Shaw et al., CORRELATION OF IN-VITRO DRUG-SENSITIVITY TESTING RESULTS WITH RESPONSE TO CHEMOTHERAPY AND SURVIVAL - COMPARISON OF NONSMALL CELL LUNG-CANCER AND SMALL-CELL LUNG-CANCER, Journal of cellular biochemistry, 1996, pp. 173-185
MYC FAMILY DNA AMPLIFICATION IN 126 TUMOR-CELL LINES FROM PATIENTS WITH SMALL-CELL LUNG-CANCER
Authors: JOHNSON BE RUSSELL E SIMMONS AM PHELPS R STEINBERG SM IHDE DC GAZDAR AF
Citation: Be. Johnson et al., MYC FAMILY DNA AMPLIFICATION IN 126 TUMOR-CELL LINES FROM PATIENTS WITH SMALL-CELL LUNG-CANCER, Journal of cellular biochemistry, 1996, pp. 210-217
OBESITY AND THERAPY-RELATED TOXICITY IN PATIENTS TREATED FOR SMALL-CELL LUNG-CANCER
Authors: GEORGIADIS MS STEINBERG SM HANKINS LA IHDE DC JOHNSON BE
Citation: Ms. Georgiadis et al., OBESITY AND THERAPY-RELATED TOXICITY IN PATIENTS TREATED FOR SMALL-CELL LUNG-CANCER, Journal of the National Cancer Institute, 87(5), 1995, pp. 361-366
CURRENT PERSPECTIVES IN THE TREATMENT OF SMALL-CELL LUNG-CANCER - EDUCATIONAL SYMPOSIUM OF THE VII WORLD CONGRESS ON LUNG-CANCER - INTRODUCTION
Authors: IHDE DC
Citation: Dc. Ihde, CURRENT PERSPECTIVES IN THE TREATMENT OF SMALL-CELL LUNG-CANCER - EDUCATIONAL SYMPOSIUM OF THE VII WORLD CONGRESS ON LUNG-CANCER - INTRODUCTION, Lung cancer, 12, 1995, pp. 1-3
SMALL-CELL LUNG-CANCER - STATE-OF-THE-ART THERAPY 1994
Authors: IHDE DC
Citation: Dc. Ihde, SMALL-CELL LUNG-CANCER - STATE-OF-THE-ART THERAPY 1994, Chest, 107(6), 1995, pp. 243-248
CALCITONIN ELEVATION IN SMALL-CELL LUNG-CANCER WITHOUT ECTOPIC PRODUCTION
Authors: KELLEY MJ BECKER KL RUSHIN JM VENZON D PHELPS R IHDE DC BLISS DP MELBY K SNIDER RH JOHNSON BE
Citation: Mj. Kelley et al., CALCITONIN ELEVATION IN SMALL-CELL LUNG-CANCER WITHOUT ECTOPIC PRODUCTION, American journal of respiratory and critical care medicine, 149(1), 1994, pp. 183-190
PROSPECTIVE RANDOMIZED COMPARISON OF HIGH-DOSE AND STANDARD-DOSE ETOPOSIDE AND CISPLATIN CHEMOTHERAPY IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER
Authors: IHDE DC MULSHINE JL KRAMER BS STEINBERG SM LINNOILA RI GAZDAR AF EDISON M PHELPS RM LESAR M PHARES JC GRAYSON J MINNA JD JOHNSON BE
Citation: Dc. Ihde et al., PROSPECTIVE RANDOMIZED COMPARISON OF HIGH-DOSE AND STANDARD-DOSE ETOPOSIDE AND CISPLATIN CHEMOTHERAPY IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 12(10), 1994, pp. 2022-2034
PHASE-II TRIAL OF FLUDARABINE PHOSPHATE AND INTERFERON ALFA-2A IN ADVANCED MYCOSIS-FUNGOIDES SEZARY-SYNDROME
Authors: FOSS FM IHDE DC LINNOILA IR FISCHMANN AB SCHECHTER GP COTELINGAM JD STEINBERG SM GHOSH BC STOCKER JL BASTIAN A PHARES JC SAUSVILLE EA
Citation: Fm. Foss et al., PHASE-II TRIAL OF FLUDARABINE PHOSPHATE AND INTERFERON ALFA-2A IN ADVANCED MYCOSIS-FUNGOIDES SEZARY-SYNDROME, Journal of clinical oncology, 12(10), 1994, pp. 2051-2059
REPORT OF THE 7TH INTERNATIONAL-SYMPOSIUM OF THE FOUNDATION-FOR-PROMOTION-OF-CANCER-RESEARCH - FUNDAMENTAL AND CLINICAL RESEARCH IN LUNG-CANCER
Authors: GAZDAR AF IHDE DC SAIJO N SHIMOYAMA M YOKOTA J
Citation: Af. Gazdar et al., REPORT OF THE 7TH INTERNATIONAL-SYMPOSIUM OF THE FOUNDATION-FOR-PROMOTION-OF-CANCER-RESEARCH - FUNDAMENTAL AND CLINICAL RESEARCH IN LUNG-CANCER, Japanese Journal of Clinical Oncology, 24(4), 1994, pp. 233-239
EFFECT OF THORACIC RADIOTHERAPY ON MORTALITY IN LIMITED SMALL-CELL LUNG-CANCER - A METAANALYSIS OF 13 RANDOMIZED TRIALS AMONG 2,140 PATIENTS
Authors: ARRIAGADA R PIGNON JP IHDE DC JOHNSON DH PERRY MC SOUHAMI RL BRODIN O JOSS RA KIES MS LEBEAU B ONOSHI T OSTERLIND K TATTERSALL MHN WAGNER H
Citation: R. Arriagada et al., EFFECT OF THORACIC RADIOTHERAPY ON MORTALITY IN LIMITED SMALL-CELL LUNG-CANCER - A METAANALYSIS OF 13 RANDOMIZED TRIALS AMONG 2,140 PATIENTS, Anticancer research, 14(1B), 1994, pp. 333-335
IS THERE A PLACE FOR CLASSICAL ADJUVANT TREATMENT
Authors: IHDE DC
Citation: Dc. Ihde, IS THERE A PLACE FOR CLASSICAL ADJUVANT TREATMENT, Lung cancer, 11, 1994, pp. 111-116
INTEGRATED CLINICAL AND BASIC STUDIES RELATED TO CIRCUMVENTING NONSMALL CELL LUNG-CANCER DRUG-RESISTANCE
Authors: MULSHINE JL JOHNSON BE GAZDAR AF SHAW GL KRAMER BS MITSUDOMI T MINNA JD PASS H PHELPS R GHOSH B LINNOILA RI IHDE DC
Citation: Jl. Mulshine et al., INTEGRATED CLINICAL AND BASIC STUDIES RELATED TO CIRCUMVENTING NONSMALL CELL LUNG-CANCER DRUG-RESISTANCE, Lung cancer, 10, 1994, pp. 190000073-190000081
NBSS REVISITED - AGAIN
Authors: IHDE DC CHAPPELL J
Citation: Dc. Ihde et J. Chappell, NBSS REVISITED - AGAIN, Journal of the National Cancer Institute, 85(21), 1993, pp. 1771-1771
PHASE-I TRIAL OF DIHYDROLENPERONE IN LUNG-CANCER PATIENTS - A NOVEL COMPOUND WITH INVITRO ACTIVITY AGAINST LUNG-CANCER
Authors: JOHNSON BE PARKER R TSAI CM BALTZ J MILLER MJ SHOEMAKER R PHELPS R BASTIAN A STOCKER J PHARES J MULSHINE JL GAZDAR AF IHDE DC
Citation: Be. Johnson et al., PHASE-I TRIAL OF DIHYDROLENPERONE IN LUNG-CANCER PATIENTS - A NOVEL COMPOUND WITH INVITRO ACTIVITY AGAINST LUNG-CANCER, Investigational new drugs, 11(1), 1993, pp. 29-37
INDIVIDUALIZED CHEMOTHERAPY FOR PATIENTS WITH NONSMALL CELL LUNG-CANCER DETERMINED BY PROSPECTIVE IDENTIFICATION OF NEUROENDOCRINE MARKERS AND IN-VITRO DRUG-SENSITIVITY TESTING
Authors: SHAW GL GAZDAR AF PHELPS R LINNOILA RI IHDE DC JOHNSON BE OIE HK PASS HI STEINBERG SM GHOSH BC WALSH TE NESBITT JC COTELINGAM JD MINNA JD MULSHINE JL
Citation: Gl. Shaw et al., INDIVIDUALIZED CHEMOTHERAPY FOR PATIENTS WITH NONSMALL CELL LUNG-CANCER DETERMINED BY PROSPECTIVE IDENTIFICATION OF NEUROENDOCRINE MARKERS AND IN-VITRO DRUG-SENSITIVITY TESTING, Cancer research, 53(21), 1993, pp. 5181-5187
SMOKING CESSATION AFTER SUCCESSFUL TREATMENT OF SMALL-CELL LUNG-CANCER IS ASSOCIATED WITH FEWER SMOKING-RELATED 2ND PRIMARY CANCERS
Authors: RICHARDSON GE TUCKER MA VENZON DJ LINNOILA RI PHELPS R PHARES JC EDISON M IHDE DC JOHNSON BE
Citation: Ge. Richardson et al., SMOKING CESSATION AFTER SUCCESSFUL TREATMENT OF SMALL-CELL LUNG-CANCER IS ASSOCIATED WITH FEWER SMOKING-RELATED 2ND PRIMARY CANCERS, Annals of internal medicine, 119(5), 1993, pp. 383-390
Risultati: 1-23 |